Yongliang Yang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Simultaneous Determination

Drug Administration

Top Venues

Nature communications

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Jiawen Bu, Yixiao Zhang, Sijin Wu, Haonan Li, Lisha Sun, Yang Liu, Xudong Zhu, Xinbo Qiao, Qingtian Ma, Chao Liu, Nan Niu, Jinqi Xue, Guanglei Chen, Yongliang Yang, Caigang Liu
KK-LC-1 as a therapeutic target to eliminate ALDH + stem cells in triple negative breast cancer. Nature communications 14 (1) (2023)
Jiawen Bu, Yixiao Zhang, Sijin Wu, Haonan Li, Lisha Sun, Yang Liu, Xudong Zhu, Xinbo Qiao, Qingtian Ma, Chao Liu, Nan Niu, Jinqi Xue, Guanglei Chen, Yongliang Yang, Caigang Liu
KK-LC-1 as a therapeutic target to eliminate ALDH + stem cells in triple negative breast cancer. Nature communications 14 (1) (2023)
Caigang Liu, Hong Yu, Guanglei Chen, Qichao Yang, Zichu Wang, Nan Niu, Ling Han, Dongyu Zhao, Manji Wang, Yuanyuan Liu, Yongliang Yang
An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: a nonrandomized controlled trial. eLife 12 (2023)
Jiawen Bu, Yixiao Zhang, Sijin Wu, Haonan Li, Lisha Sun, Yang Liu, Xudong Zhu, Xinbo Qiao, Qingtian Ma, Chao Liu, Nan Niu, Jinqi Xue, Guanglei Chen, Yongliang Yang, Caigang Liu
KK-LC-1 as a therapeutic target to eliminate ALDH + stem cells in triple negative breast cancer. Nature communications 14 (1) (2023)
He Liu, Meisuo Liu, Xibao Tian, Haina Wang, Jiujiao Gao, Hanrui Li, Zhehuan Zhao, Yu Liu, Caigang Liu, Xuan Chen, Yongliang Yang
Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma. eLife 12 (2023)
Caigang Liu, Hong Yu, Guanglei Chen, Qichao Yang, Zichu Wang, Nan Niu, Ling Han, Dongyu Zhao, Manji Wang, Yuanyuan Liu, Yongliang Yang
An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: a nonrandomized controlled trial. eLife 12 (2023)
Jiawen Bu, Yixiao Zhang, Sijin Wu, Haonan Li, Lisha Sun, Yang Liu, Xudong Zhu, Xinbo Qiao, Qingtian Ma, Chao Liu, Nan Niu, Jinqi Xue, Guanglei Chen, Yongliang Yang, Caigang Liu
KK-LC-1 as a therapeutic target to eliminate ALDH + stem cells in triple negative breast cancer. Nature communications 14 (1) (2023)
Wen Su, Sijin Wu, Yongliang Yang, Yanlin Guo, Haibo Zhang, Jie Su, Lei Chen, Zhuo Mao, Rongfeng Lan, Rong Cao, Chunjiong Wang, Hu Xu, Cong Zhang, Sha Li, Min Gao, Xiaocong Chen, Zhiyou Zheng, Bing Wang, Yi'ao Liu, Zuojun Liu, Zimei Wang, Bao-Hua Liu, Xinmin Fan, Xiao-Yan Zhang, Youfei Guan
Phosphorylation of 17β-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice. Nature communications 13 (1) (2022)
Yixiao Zhang, Yuan Yao, Peng Chen, Yu Liu, Hao Zhang, He Liu, Yu Liu, Hong Xu, Xibao Tian, Zichu Wang, Peng Chu, Dongyu Zhao, Hongxu Liu, Chenlei Zhang, Shuyuan Chen, Yuhong Zhao, Caigang Liu, Yongliang Yang
Checkpoint therapeutic target database (CKTTD): the first comprehensive database for checkpoint targets and their modulators in cancer immunotherapy. Journal for immunotherapy of cancer 8 (2) (2021)
Jiujiao Gao, Peng Chu, Caigang Liu, Zhaolin Sun, Quentin Liu, Yongliang Yang
Discovery and biological evaluation of a small-molecule inhibitor of CRM1 that suppresses the growth of triple-negative breast cancer cells. Traffic (Copenhagen, Denmark) 22 (7) (2021)
Xibao Tian, Jiali Gao, Meishuo Liu, Yuqin Lei, Fang-Jun Wang, Jin Chen, Peng Chu, Jiujiao Gao, Feida Long, Minzhi Liang, Xiangyu Long, Huiying Chu, Cuixia Liu, Xueliang Li, Qingxiang Sun, Guo-Hui Li, Yongliang Yang
Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery. Journal of medicinal chemistry 63 (8) (2020)
Lei Feng, Yongliang Yang, Xiaokui Huo, Xiangge Tian, Yujie Feng, Hanwen Yuan, Lijian Zhao, Chao Wang, Peng Chu, Feida Long, Wei Wang, Xiao-Chi Ma
Correction to Highly Selective NIR Probe for Intestinal β-Glucuronidase and High-Throughput Screening Inhibitors to Therapy Intestinal Damage. ACS sensors 4 (9) (2019)
Lei Feng, Yongliang Yang, Xiaokui Huo, Xiangge Tian, Yujie Feng, Hanwen Yuan, Lijian Zhao, Chao Wang, Peng Chu, Feida Long, Wei Wang, Xiao-Chi Ma
Highly Selective NIR Probe for Intestinal β-Glucuronidase and High-Throughput Screening Inhibitors to Therapy Intestinal Damage. ACS sensors 3 (9) (2018)
Lan Feng, Nannan Shi, Shasha Cai, Xue Qiao, Peng Chu, Hui Wang, Feida Long, Huaixin Yang, Yongliang Yang, Yipeng Wang, Haining Yu
De Novo Molecular Design of a Novel Octapeptide That Inhibits In Vivo Melanogenesis and Has Great Transdermal Ability. Journal of medicinal chemistry 61 (15) (2018)